Jbs N.V. (JBS)
NYSE:JBS
Want to see JBS full AI Analyst Report?
Top Page
JBS
(NYSE:JBS)
Select Model
Select Model
Rating:49Neutral
Price Target:
$14.00
▼(-20.95% Downside)
Action:Reiterated
Date:05/15/26
The score is held down primarily by weakening near-term fundamentals (TTM revenue drop, negative/weak free cash flow, and high leverage) and bearish technicals (below key moving averages with weak momentum). A high dividend yield and a mixed-but-stable earnings call (record sales and liquidity offset by cash burn and tougher 2026 outlook) provide partial support but do not outweigh the core risks.
Positive Factors
Vertical integration & diversified protein portfolio
JBS's vertically integrated model and multi-protein footprint give enduring control over supply, capture co-product value (hides, rendering) and diversify revenue by product and geography. That structural setup supports margin capture and resilience across cycles and markets over months.
Negative Factors
Elevated leverage
Leverage near the upper bound of the target range constrains flexibility: higher interest expense and limited balance-sheet room increase vulnerability if margins or volumes worsen. Over a multi-month horizon this reduces capacity for aggressive buybacks or cushioning prolonged downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Vertical integration & diversified protein portfolio
JBS's vertically integrated model and multi-protein footprint give enduring control over supply, capture co-product value (hides, rendering) and diversify revenue by product and geography. That structural setup supports margin capture and resilience across cycles and markets over months.
Read all positive factors
JBS (JBS) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$13.05B
Dividend Yield9.72%
Average Volume (3M)8.20M
Price to Earnings (P/E)7.1
Beta (1Y)0.10
Revenue GrowthN/A
EPS Growth70.95%
CountryUS
Employees280,000
SectorGeneral
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)5.22
Shares Outstanding773,666,700
10 Day Avg. Volume11,442,450
30 Day Avg. Volume8,199,942
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.76
Price to Sales (P/S)0.18
P/FCF Ratio20.44
Enterprise Value/Market Cap18.54
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit4.11
Enterprise Value/Ebitda7.23
Forecast
1Y Price Target
$19.03Price Target Upside7.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)1.36
Revenue Forecast (FY)$93.06B
JBS Business Overview & Revenue Model
Company Description
JBS N.V., together with its subsidiaries, operates as a protein and food company worldwide. The company offers beef, pork, chicken, poultry, fish, and lamb products; cooked frozen meat; plant based products; and other food products. It also sells ...
How the Company Makes Money
JBS makes money mainly by selling meat and prepared food products through a vertically integrated protein production and processing model. Its core revenue streams come from: (1) Fresh and frozen beef, pork, and poultry sales to retailers (e.g., s...
JBS Earnings Call Summary
Earnings Call Date:May 12, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 10, 2026
Earnings Call Sentiment Neutral
The call presented a mixed picture: the company achieved record first-quarter net sales and maintained positive adjusted EBITDA, with strong margins in key platforms (Seara, Brazil, Australia), meaningful liquidity and strategic actions (debt refinancing, AI/automation scaling, SEC filings). However, significant near-term headwinds — most notably the large free cash flow deficit, a negative U.S. beef result (≈$230M EBITDA loss), an adjusted EBITDA decline of ~ $400M year-over-year, higher expansion CapEx and working capital timing effects — temper the positive items. Management emphasized operational adjustments, cost discipline and confidence in seasonal recovery later in the year but acknowledged 2026 will be more challenging than 2025. Overall, positives and negatives are roughly balanced: strong top-line and strategic positioning offset by material cash and segment-level pressures.Positive Updates
Record Quarterly Net Sales
Company reported record first-quarter net sales of roughly $21–22 billion, representing net sales growth of 11% year-over-year.
Negative Updates
U.S. Beef Segment Weakness
Beef North America posted a negative EBITDA of ~$230 million with a negative margin of about 2.3%, driven by difficult cattle supply dynamics, higher costs, seasonality and necessary plant footprint/efficiency adjustments. Management noted U.S. beef will remain challenging and that 2026 is expected to be tougher than 2025.
Read all updates
Q1-2026 Updates
Positive
Negative
Record Quarterly Net Sales
Company reported record first-quarter net sales of roughly $21–22 billion, representing net sales growth of 11% year-over-year.
Read all positive updates
Company Guidance
JBS guided that, despite record Q1 net sales of roughly $21–22 billion (≈11% y/y), adjusted EBITDA was about $1.1 billion (IFRS; 5.2% margin) and $960 million (U.S. GAAP; 4.2% margin), with net income ≈$222 million (EPS $0.21; adjusted net income $241 million, EPS $0.23), ROE 22% and ROIC 15%. Q1 free cash flow was negative $1.5 billion (vs. -$970 million a year ago) after Q1 CapEx of $566 million (expansion CapEx ≈$390 million); management reiterated ~ $1 billion of growth CapEx within a broader ~$2.4 billion CapEx framework and said it expects stronger cash generation in H2. Leverage is ~2.7x (2.77x), inside the 2.0–3.0x long‑term target, with average debt tenor ~15.6 years, average cost ~5.7%, no material maturities until 2031, $3.5 billion cash and $3.4 billion RCF (after issuing $2.5 billion bonds and a $1.45 billion tender); breakeven cash‑flow EBITDA was indicated at $5.7–6.0 billion. Management flagged 2026 as likely tougher than 2025 (market margins ~1.0–1.5 pp lower), but expects U.S. beef trends to improve, will keep disciplined capital allocation (including a ~ $1 billion June dividend and a 3.75% dividend limit) and will begin filing 10‑K/10‑Q to broaden index eligibility.JBS Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
52
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 477.26B | 471.14B | 416.95B | 363.82B | 383.97B | 362.50B |
| Gross Profit | 58.78B | 60.33B | 62.77B | 39.65B | 61.04B | 68.49B |
| EBITDA | 33.44B | 35.25B | 35.39B | 14.72B | 35.98B | 42.98B |
| Net Income | 9.55B | 11.10B | 9.62B | -1.06B | 15.85B | 21.24B |
Balance Sheet | ||||||
| Total Assets | 232.92B | 248.34B | 1.56T | 1.01T | 208.11B | 207.25B |
| Cash, Cash Equivalents and Short-Term Investments | 17.80B | 25.98B | 214.97B | 108.74B | 13.18B | 23.24B |
| Total Debt | 119.33B | 125.71B | 834.39B | 542.27B | 104.41B | 103.61B |
| Total Liabilities | 186.21B | 195.97B | 1.25T | 782.17B | 158.30B | 159.45B |
| Stockholders Equity | 42.44B | 47.87B | 276.92B | 213.08B | 46.34B | 44.12B |
Cash Flow | ||||||
| Free Cash Flow | 2.29B | 4.13B | 15.47B | 4.01B | 2.11B | 11.86B |
| Operating Cash Flow | 15.17B | 15.49B | 23.56B | 11.50B | 13.33B | 21.48B |
| Investing Cash Flow | -14.01B | -12.56B | -7.73B | -7.02B | -13.12B | -18.86B |
| Financing Cash Flow | -10.06B | -9.97B | -7.30B | 5.01B | -8.76B | -844.50M |
JBS Technical Analysis
Negative
17.71
Price Trends
14.74
Negative
14.62
Negative
13.92
Negative
Market Momentum
-0.71
Positive
35.69
Neutral
18.81
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JBS, the sentiment is Negative. The current price of 17.71 is above the 20-day moving average (MA) of 12.97, above the 50-day MA of 14.74, and above the 200-day MA of 13.92, indicating a bearish trend. The MACD of -0.71 indicates Positive momentum. The RSI at 35.69 is Neutral, neither overbought nor oversold. The STOCH value of 18.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JBS.
JBS Risk Analysis
JBS disclosed 49 risk factors in its most recent earnings report. JBS reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
JBS Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $6.89B | 8.00 | 24.19% | ― | 3.30% | -26.64% | |
62 Neutral | $26.64B | -4.66 | -13.85% | 6.75% | -1.75% | -319.68% | |
61 Neutral | $12.82B | 27.85 | 5.86% | 4.82% | 2.47% | -37.67% | |
61 Neutral | $10.78B | -8.80 | -21.55% | 4.45% | 1.58% | -389.82% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | $13.05B | 7.10 | 26.35% | 9.72% | ― | 70.95% |
* General Sector Average
JBS
JBS
12.24
-0.97
-7.35%
HRL
Hormel Foods
23.62
-5.58
-19.11%
SJM
JM Smucker
103.54
-2.89
-2.72%
PPC
Pilgrim's Pride
29.88
-15.03
-33.46%
KHC
Kraft Heinz
22.58
-2.47
-9.86%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.